Publications
Detailed Information
The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yu, Sung Hoon | - |
dc.contributor.author | Park, Sunmin | - |
dc.contributor.author | Kim, Hun-Sung | - |
dc.contributor.author | Park, So-Young | - |
dc.contributor.author | Han, Ki Ok | - |
dc.contributor.author | Jang, Hak Chul | - |
dc.contributor.author | Kim, Sung-Hoon | - |
dc.contributor.author | Chung, Ho Yeon | - |
dc.contributor.author | Yoon, Hyun Koo | - |
dc.contributor.author | Yim, Chang Hoon | - |
dc.date.accessioned | 2012-05-24T07:21:21Z | - |
dc.date.available | 2012-05-24T07:21:21Z | - |
dc.date.issued | 2009-05 | - |
dc.identifier.citation | DIABETES-METABOLISM RESEARCH AND REVIEWS; Vol.25 4; 329-334 | ko_KR |
dc.identifier.issn | 1520-7552 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76438 | - |
dc.description.abstract | Background We conducted this research in order to evaluate the prevalence of glutamic acid decarboxylase antibodies (GADA) in Korean women with gestational diabetes mellitus (GDM), to identify the clinical characteristics of these women, and to gauge the prevalence of diabetes among them after childbirth. Methods We studied 887 Korean women with GDM who were screened for GADA, and assessed their antepartum clinical characteristics and the outcomes of their pregnancies. At 6 weeks` postpartum, 75 g oral glucose tolerance tests were performed to determine the diabetic status of GDM women with GADA. Results The prevalence of GADA in Korean women with GDM was 1.7%. Plasma glucose levels at 0- and 3-h during oral glucose tolerance tests were significantly different between GADA-positive and GADA-negative women with GDM. There were no significant differences between them in terms of age, body mass index, family history of diabetes, fasting insulin, and lipid profiles. However, GADA-positive women with GDM required insulin treatment during pregnancy more frequently than GADA-negative patients. The development of diabetes at early postpartum was significantly higher in GADA-positive women with GDM than those who were GADA negative. Conclusions The prevalence of GADA in Korean women with GDM was low. However, GADA-positive women with GDM are more susceptible to subsequently developing type 1 diabetes, even in the early postpartum period. Long-term follow up studies and intervention to prevent type 1 diabetes among GADA-positive GDM women are needed. Copyright (C) 2009 John Wiley & Sons, Ltd. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | JOHN WILEY & SONS LTD | ko_KR |
dc.subject | Gestational diabetes mellitus | ko_KR |
dc.subject | postpartum diabetes | ko_KR |
dc.subject | prevalence | ko_KR |
dc.subject | Korean | ko_KR |
dc.subject | glutamic acid decarboxylase antibody | ko_KR |
dc.title | The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 유성훈 | - |
dc.contributor.AlternativeAuthor | 박선민 | - |
dc.contributor.AlternativeAuthor | 김훈성 | - |
dc.contributor.AlternativeAuthor | 박소영 | - |
dc.contributor.AlternativeAuthor | 임창훈 | - |
dc.contributor.AlternativeAuthor | 한기옥 | - |
dc.contributor.AlternativeAuthor | 윤현구 | - |
dc.contributor.AlternativeAuthor | 장학철 | - |
dc.contributor.AlternativeAuthor | 정호연 | - |
dc.contributor.AlternativeAuthor | 김성훈 | - |
dc.identifier.doi | 10.1002/dmrr.963 | - |
dc.citation.journaltitle | DIABETES-METABOLISM RESEARCH AND REVIEWS | - |
dc.description.citedreference | Wenzlau JM, 2008, CURR OPIN ENDOCRINOL, V15, P315, DOI 10.1097/MED.0b013e328308192b | - |
dc.description.citedreference | Nilsson C, 2007, DIABETES CARE, V30, P1968, DOI 10.2337/dc07-0157 | - |
dc.description.citedreference | Buchanan TA, 2007, DIABETES CARE, V30, pS105, DOI 10.2337/dc07-s201 | - |
dc.description.citedreference | Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206 | - |
dc.description.citedreference | De Leiva A, 2007, DIABETES CARE, V30, pS127, DOI 10.2337/dc07-s204 | - |
dc.description.citedreference | Buzzetti R, 2007, DIABETES CARE, V30, P932, DOI 10.2337/dc06-1696 | - |
dc.description.citedreference | Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x | - |
dc.description.citedreference | Lobner K, 2006, DIABETES, V55, P792 | - |
dc.description.citedreference | Jarvela IY, 2006, DIABETES CARE, V29, P607 | - |
dc.description.citedreference | Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973 | - |
dc.description.citedreference | Bottazzo GF, 2005, DIABETOLOGIA, V48, P703, DOI 10.1007/s00125-005-1691-9 | - |
dc.description.citedreference | Damanhouri LH, 2005, DIABETIC MED, V22, P448 | - |
dc.description.citedreference | *AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS4, DOI DOI 10.2337/DIACARE | - |
dc.description.citedreference | Kobayashi T, 2003, J CLIN ENDOCR METAB, V88, P4768, DOI 10.1210/jc.2002-021529 | - |
dc.description.citedreference | Jang HC, 2003, DIABETES RES CLIN PR, V61, P117, DOI 10.1016/S0168-8227(03)00110-4 | - |
dc.description.citedreference | Erem C, 2003, EUR J EPIDEMIOL, V18, P39, DOI 10.1023/A:1022585101209 | - |
dc.description.citedreference | Bo S, 2003, DIABETIC MED, V20, P64 | - |
dc.description.citedreference | Kim C, 2002, DIABETES CARE, V25, P1862 | - |
dc.description.citedreference | Aberg AEB, 2002, ACTA OBSTET GYN SCAN, V81, P11 | - |
dc.description.citedreference | Lapolla A, 2002, ANN NY ACAD SCI, V958, P263 | - |
dc.description.citedreference | Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516 | - |
dc.description.citedreference | Mitchell ML, 2000, DIABETES CARE, V23, P1705 | - |
dc.description.citedreference | Buchanan TA, 1999, J CLIN ENDOCR METAB, V84, P1854 | - |
dc.description.citedreference | King H, 1998, DIABETES CARE, V21, pB9 | - |
dc.description.citedreference | Kulmala P, 1998, J CLIN INVEST, V101, P327 | - |
dc.description.citedreference | Fuchtenbusch M, 1997, DIABETES, V46, P1459 | - |
dc.description.citedreference | FALLUCCA F, 1997, ANN I SUPER SANITA, V33, P425 | - |
dc.description.citedreference | Dozio N, 1997, DIABETES CARE, V20, P81 | - |
dc.description.citedreference | JANG HC, 1995, INT J GYNECOL OBSTET, V51, P115 | - |
dc.description.citedreference | BEISCHER NA, 1995, AM J OBSTET GYNECOL, V173, P1563 | - |
dc.description.citedreference | DAMM P, 1994, DIABETIC MED, V11, P558 | - |
dc.description.citedreference | EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360 | - |
dc.description.citedreference | MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412 | - |
dc.description.citedreference | CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768 | - |
dc.description.citedreference | GORSUCH AN, 1981, LANCET, V2, P1363 | - |
dc.description.citedreference | AMANKWAH KS, 1977, OBSTET GYNECOL, V49, P497 | - |
dc.description.citedreference | OSULLIVAN JB, 1964, DIABETES, V13, P278 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.